Neuberger Berman Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $844K | Buy |
3,029
+19
| +0.6% | +$5.47K | ﹤0.01% | 1472 |
|
|
2025
Q4 | $912K | Buy |
3,010
+193
| +7% | +$60.2K | ﹤0.01% | 1432 |
|
|
2025
Q3 | $790K | Buy |
2,817
+1,201
| +74% | +$327K | ﹤0.01% | 1441 |
|
|
2025
Q2 | $390K | Sell |
1,616
-31
| -2% | -$7.33K | ﹤0.01% | 1658 |
|
|
2025
Q1 | $401K | Sell |
1,647
-1,252
| -43% | -$377K | ﹤0.01% | 1600 |
|
|
2024
Q4 | $952K | Buy |
2,899
+6
| +0.2% | +$2.04K | ﹤0.01% | 1325 |
|
|
2024
Q3 | $968K | Buy |
2,893
+1,017
| +54% | +$323K | ﹤0.01% | 1310 |
|
|
2024
Q2 | $512K | Sell |
1,876
-44
| -2% | -$12.8K | ﹤0.01% | 1487 |
|
|
2024
Q1 | $664K | Buy |
1,920
+76
| +4% | +$25K | ﹤0.01% | 1400 |
|
|
2023
Q4 | $595K | Sell |
1,844
-56,721
| -97% | -$17.8M | ﹤0.01% | 1439 |
|
|
2023
Q3 | $21M | Buy |
58,565
+662
| +1% | +$255K | 0.02% | 594 |
|
|
2023
Q2 | $22M | Buy |
57,903
+147
| +0.3% | +$59.8K | 0.02% | 594 |
|
|
2023
Q1 | $27.7M | Buy |
57,756
+20
| +0% | +$9.36K | 0.03% | 550 |
|
|
2022
Q4 | $24.3M | Buy |
57,736
+401
| +0.7% | +$162K | 0.02% | 573 |
|
|
2022
Q3 | $23.9M | Sell |
57,335
-433
| -0.7% | -$216K | 0.03% | 574 |
|
|
2022
Q2 | $28.6M | Buy |
57,768
+3,075
| +6% | +$1.6M | 0.03% | 545 |
|
|
2022
Q1 | $30.8M | Buy |
54,693
+58
| +0.1% | +$35K | 0.03% | 578 |
|
|
2021
Q4 | $41.1M | Buy |
54,635
+595
| +1% | +$445K | 0.03% | 523 |
|
|
2021
Q3 | $40.2M | Sell |
54,040
-24,713
| -31% | -$18.5M | 0.04% | 518 |
|
|
2021
Q2 | $50.6M | Buy |
78,753
+14,834
| +23% | +$9.03M | 0.04% | 462 |
|
|
2021
Q1 | $36.5M | Buy |
63,919
+10,698
| +20% | +$6.34M | 0.03% | 523 |
|
|
2020
Q4 | $31M | Sell |
53,221
-11,206
| -17% | -$6.38M | 0.03% | 531 |
|
|
2020
Q3 | $33.2M | Buy |
64,427
+33
| +0.1% | +$16.7K | 0.04% | 454 |
|
|
2020
Q2 | $29.1M | Buy |
64,394
+153
| +0.2% | +$67.5K | 0.04% | 479 |
|
|
2020
Q1 | $22.5M | Sell |
64,241
-29,992
| -32% | -$11M | 0.03% | 488 |
|
|
2019
Q4 | $34.9M | Sell |
94,233
-20,459
| -18% | -$7.21M | 0.04% | 473 |
|
|
2019
Q3 | $38.2M | Buy |
114,692
+5
| +0% | +$1.63K | 0.05% | 437 |
|
|
2019
Q2 | $35.9M | Sell |
114,687
-24
| -0% | -$7.19K | 0.04% | 462 |
|
|
2019
Q1 | $35.1M | Buy |
114,711
+201
| +0.2% | +$54.2K | 0.04% | 467 |
|
|
2018
Q4 | $26.6M | Sell |
114,510
-873
| -0.8% | -$234K | 0.04% | 491 |
|
|
2018
Q3 | $36.1M | Sell |
115,383
-1,117
| -1% | -$347K | 0.04% | 485 |
|
|
2018
Q2 | $33.6M | Sell |
116,500
-13,500
| -10% | -$3.73M | 0.04% | 504 |
|
|
2018
Q1 | $32.5M | Sell |
130,000
-1,273
| -1% | -$324K | 0.04% | 509 |
|
|
2017
Q4 | $31.3M | Sell |
131,273
-120
| -0.1% | -$29.1K | 0.04% | 530 |
|
|
2017
Q3 | $29.2M | Buy |
131,393
+22,050
| +20% | +$4.96M | 0.04% | 524 |
|
|
2017
Q2 | $24.7M | Buy |
109,343
+23,116
| +27% | +$5.04M | 0.03% | 558 |
|
|
2017
Q1 | $17.2M | Buy |
86,227
+33,264
| +63% | +$6.41M | 0.02% | 635 |
|
|
2016
Q4 | $9.65M | Buy |
+52,963
| New | +$9.03M | 0.01% | 751 |
|
Other funds holding BIO
VCM
VPM
AI
